SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as the community eagerly anticipates imminent Phase 3 REGAL trial results for its AML immunotherapy, with many expecting a positive readout to trigger a massive short squeeze and a potential buyout by a major pharmaceutical company. The extended trial duration is widely interpreted as a strong bullish signal, reinforcing conviction in the drug's life-saving efficacy.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is a hot topic as investors weigh its deep undervaluationhighlighted by significant cash reserves and a low P/E ahead of its upcoming earningsagainst persistent stock underperformance, fierce competition from peers, and ongoing geopolitical concerns impacting China tech.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull (BULL) is trending following a mixed earnings report that showed strong revenue growth and record customer assets, though initial confusion around EPS figures and increased operating expenses for global expansion have fueled market volatility. The community is actively debating the stock's potential undervaluation compared to competitors like Robinhood, while also expressing concerns over perceived stock manipulation and past dilution deals despite optimistic long-term growth prospects for the platform.

Gold.com, Inc. engages in the trading of gold, silver, platinum, and palladium bullion numismatic coins, and related products. It operates through the following segments: Wholesale Trading and Ancillary Services, Direct-to-Consumer, and Secured Lending. The Wholesale Trading and Ancillary Services segment is involved in the distribution and purchasing of metal products from sovereign and private mints. The Direct-to-Consumer segment provides access to a multitude of products through its wholly owned subsidiaries. The Secured Lending segment includes coin and precious metal dealers, investors, and collectors. The company was founded by Steven C. Markoff on April 9, 1965 and is headquartered in El Segundo, CA.

Gold.com Inc.

Gold.com Inc. ($GOLD) is trending following its robust Q2 earnings report, which highlighted record revenue growth and a strategic investment from Tether. This positive company-specific news aligns with a broader bullish sentiment for gold, driven by safe-haven demand amidst geopolitical tensions and strong central bank buying.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending after reporting robust earnings and strong guidance, driven by accelerating demand for its AI semiconductor solutions. The community is buzzing about the long-term outlook for AI chip revenue and its expanded customer base, including a new partnership with OpenAI, which is seen as reaffirming its critical role in the AI infrastructure build-out.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is seeing significant volatility as market participants grapple with conflicting narratives around Middle East geopolitical developments and rising oil prices, with much community discussion questioning if rallies are genuine de-escalation or orchestrated manipulations.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending following CEO Jeff Green's record insider share purchase of $148 million, which, alongside widespread reports of a potential OpenAI partnership for ad sales, has sparked community speculation about a significant short squeeze and renewed growth prospects for the digital advertising platform.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

ProShares UltraPro QQQ is experiencing amplified volatility as ongoing geopolitical tensions in the Middle East and concerns over oil supply drive widespread "liquidation" talk. The community is sharply divided between those "buying the dip" and anticipating a "short squeeze" or technical breakout, versus others bracing for further downside in leveraged tech.

Canadian Natural Resources Ltd. is an oil and natural gas production company, which engages in the exploration, development, marketing, and production of crude oil and natural gas. It operates through the following segments: Oil Sands Mining & Upgrading, Midstream & Refining, and Exploration & Production. The Oil Sands Mining & Upgrading segment produces synthetic crude oil through bitumen mining and upgrading operations. The Midstream & Refining segment focuses on maintaining pipeline operations and investment. The Exploration & Production segment consists of operations in North America, largely in Western Canada, the United Kingdom portion of the North Sea, and Côte d’Ivoire and South Africa in Africa. The company was founded on November 7, 1973 and is headquartered in Calgary, Canada.

Canadian Natural Resources Ltd.

Canadian Natural Resources is trending amid enthusiasm for a new Alberta pipeline deal aiming to open Asian export markets and recent Q4 2025 earnings, where management highlighted the company's "best operational year" in history; the community is closely discussing its strong production, disciplined capital allocation, and consistent dividend growth despite commodity price sensitivity.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng (XPEV) is drawing significant attention amid disappointing recent delivery figures, which have intensified bearish sentiment around its sales performance in a competitive EV market. Despite this, a strong bullish contingent argues the company is fundamentally undervalued, citing its advanced VLA 2.0 autonomous driving technology, a key partnership with Volkswagen, and long-term potential as a "physical AI platform" developing humanoid robots and flying cars.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS For those who may not know: 
Aza+VEN, the Best Available Treatment -BAT, for Control Arm Patients Recently Failed 3 Large Phase 3 Trials conducted by $ABBV Including 2 for AML Remission Maintenance. 
 
- VERONA Phase 3 Failed for High Risk MDS/ preAML 
- VIALE-T Phase 3 Failed for AML Post Transplant Maintenance 
- VIALE-M Phase 3 Failed for AML First Remission CR1 Maintenance

Dean

Paulstoxk

C. H.

thewatchmakerG48

GreyLock

Thomas Nielsen

Jeremy Dworkin

Mathew

Margaret (Peggy) Murphy

6,700% ROI this quarter

Anand

Stephen

Chessdoc

Daniel T

Benjamin

$SLS The share price will continue to climb, until it absolutely Launches. 
 
GPs is worth every nickel of $40B / $180 Per Share to Big Pharma - the Instant the Phase 3 Results are announced - and we are in the Imminent Any Day Now Zone. 
 
- if you don&#39;t understand the math, or think its high, just do some due diligence. Gps will be a revolutionary AML Remission Maintenance treatment with infinite dosing.

StockTwits Web

$SLS its not complicated.  
  
While we are seeing near miraculous ALL POOLED ( BAT / Gps patients Combined ) Survival, BAT / Aza+VEN Recently Failed 3 Large Phase 3 AML trials.

$SLS its not complicated. 
 
While we are seeing near miraculous ALL POOLED ( BAT / Gps patients Combined ), BAT / Aza+VEN Recently Failed 3 Large Phase 3 AML trials.

Abbvie Inc

 For those who may not know: 
Aza+VEN, the Best Available Treatment -BAT, for Control Arm Patients Recently Failed 3 Large Phase 3 Trials conducted by 

 Including 2 for AML Remission Maintenance. 
 
- VERONA Phase 3 Failed for High Risk MDS/ preAML 
- VIALE-T Phase 3 Failed for AML Post Transplant Maintenance 
- VIALE-M Phase 3 Failed for AML First Remission CR1 Maintenance

Bristol-Myers Squibb Co.

Merck & Co Inc

SPDR S&P Biotech ETF

Forty Seven, Inc.

MAIA Biotechnology Inc

Abivax - ADR

@67X_ROI_Q1_2026 isn’t the combination used in these stopped trials the BAT used in Regal 3?  If so there very likely may be only GPS patients still alive in Regal 3

StockTwits for iOS

 isn’t the combination used in these stopped trials the BAT used in Regal 3?  If so there very likely may be only GPS patients still alive in Regal 3

Strategy

Plug Power Inc

Rigetti Computing Inc

IREN Limited

New Era Energy & Digital Inc.

AMC Robotics Corp.

Robert Ham

@67X_ROI_Q1_2026 so may need those 2028 leaps as this thing could tarry into 2027

 so may need those 2028 leaps as this thing could tarry into 2027

@67X_ROI_Q1_2026 hope you are right, but I bought some 2028 leaps just to be on the safe side.

 hope you are right, but I bought some 2028 leaps just to be on the safe side.

@Fivgardnks just blocked you for being an obvious tool.

 just blocked you for being an obvious tool.